A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

NCT04747431 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Frontotemporal Dementia
FTD
FTD-GRN
Dementia Frontotemporal
C9orf72

Interventions

DRUG: PBFT02

Sponsor

Passage Bio, Inc.